Buscar
Mostrando ítems 11-18 de 18
Differences in outcome of heart failure with preserved or depressed systolic function in patients older than 70 years who receive beta blockers
(Elsevier, 2011-10-14)
[Abstract] Introduction and objectives. Most studies have shown that prognosis of heart failure with preserved systolic function is as poor as that of heart failure with depressed systolic function, although these results ...
Organization of heart failure care in Spain: characteristics of heart failure units
(Elsevier, 2015-05-08)
Quality of anticoagulation with vitamin K antagonists
(Wiley, 2015-05-11)
[Abstract] Background. Vitamin K antagonists (VKA) have a narrow therapeutic range, and literature analysis reveals poor quality of anticoagulation control. We sought to assess the prevalence of poor anticoagulant control ...
Calidad de vida relacionada con la salud de los pacientes con insuficiencia cardiaca crónica sistólica en España: resultados del estudio VIDA-IC
(Elsevier, 2015-12-23)
[Resumen] Introducción y objetivos. La calidad de vida relacionada con la salud de los pacientes con insuficiencia cardiaca está afectada. Hay poca información sobre los factores clínicos asociados a esta mala calidad de ...
Cardiopatía estructural en pacientes anticoagulados con fibrilación auricular no valvular: prevalencia y perfil clínico en una muestra nacional
(Sociedad Española de Cardiología, 2016-07-21)
Choice of new oral anticoagulant agents versus vitamin K antagonists in atrial fibrillation: FANTASIIA study
(SAGE, 2015-07-30)
[Abstract] Introduction: Atrial fibrillation (AF) is associated with an increased risk of thromboembolic events. Many patients with AF receive chronic anticoagulation, either with vitamin K antagonists (VKAs) or with non-VKA ...
Association of body mass index with clinical outcomes in patients with atrial fibrillation: a report from the FANTASIIA Registry
(NLM, 2019-12-24)
[Abstract]
Background.
Obesity and atrial fibrillation (AF) frequently coexist and independently increase mortality. We sought to assess the association between obesity and adverse events in patients receiving oral ...